Natural polyphenols against neurodegenerative disorders: Potentials and pitfalls

Ageing Research Reviews

Volumn 11, Issue 2, 2012, Pages 329-345

  Ebrahimi, Azadeh ^a   Schluesener, Hermann ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Alzheimer's disease; Neurodegenerative disease; Neuroprotection; Parkinson's disease; Polyphenol

Indexed keywords

3 HYDROXYFLAVONE; 6 HYDROXYFLAVONE; APIGENIN; BAICALEIN; BROMOCRIPTINE MESILATE; CHRYSIN; CYANIDIN 3 GLUCOSIDE; DELPHINIDIN; DIOSMIN; ERIODICTYOL; FISETIN; FLAVOXATE; GALANGIN; GOSSYPETIN; HESPERETIN; HESPERIDIN; ISOKAEMPFERIDE; ISORHAMNETIN; KAEMPFEROL; LUTEOLIN; MORIN; MYRICETIN; NARINGENIN; PELARGONIDIN; QUERCETIN; RESVERATROL; RHAMNETIN; SCUTELLAREIN; UNINDEXED DRUG; WOGONIN;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; CHRONIC KIDNEY DISEASE; DIETARY INTAKE; DRUG MEGADOSE; HUMAN; HYPOXIA; ISCHEMIA; LIFE EXPECTANCY; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ANTIOXIDANTS; CHOLINESTERASE INHIBITORS; HUMANS; NEURODEGENERATIVE DISEASES; NEUROPROTECTIVE AGENTS; POLYPHENOLS; SIGNAL TRANSDUCTION; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84857435066     PISSN: 15681637     EISSN: 18729649     Source Type: Journal    
DOI: 10.1016/j.arr.2012.01.006     Document Type: Review

References (316)

1. Abd El Mohsen M.M., Kuhnle G., Rechner A.R., Schroeter H., Rose S., Jenner P., Rice-Evans C.A. Uptake and metabolism of epicatechin and its access to the brain after oral ingestion. Free Radic. Biol. Med. 2002, 33:1693-1702.
2. Alkon D.L., Sun M.K., Nelson T.J. PKC signaling deficits: a mechanistic hypothesis for the origins of Alzheimer's disease. Trends Pharmacol. Sci. 2007, 28:51-60.
3. Aluise C.D., Sultana R., Tangpong J., Vore M., St Clair D., Moscow J.A., Butterfield D.A. Chemo brain (chemo fog) as a potential side effect of doxorubicin administration: role of cytokine-induced, oxidative/nitrosative stress in cognitive dysfunction. Adv. Exp. Med. Biol. 2010, 678:147-156.
4. Amazzal L., Lapotre A., Quignon F., Bagrel D. Mangiferin protects against 1-methyl-4-phenylpyridinium toxicity mediated by oxidative stress in N2A cells. Neurosci. Lett. 2007, 418:159-164.
5. Anekonda T.S. Resveratrol - a boon for treating Alzheimer's disease?. Brain Res. Rev. 2006, 52:316-326.
6. Anekonda T.S., Reddy P.H. Neuronal protection by sirtuins in Alzheimer's disease. J. Neurochem. 2006, 96:305-313.
7. Arts I.C., Hollman P.C. Polyphenols and disease risk in epidemiologic studies. Am. J. Clin. Nutr. 2005, 81:317S-325S.
8. Ataie A., Sabetkasaei M., Haghparast A., Moghaddam A.H., Kazeminejad B. Neuroprotective effects of the polyphenolic antioxidant agent, curcumin, against homocysteine-induced cognitive impairment and oxidative stress in the rat. Pharmacol. Biochem. Behav. 2010, 96:378-385.
9. Avramovich-Tirosh Y., Reznichenko L., Mit T., Zheng H., Fridkin M., Weinreb O., Mandel S., Youdim M.B. Neurorescue activity, APP regulation and amyloid-beta peptide reduction by novel multi-functional brain permeable iron- chelating-antioxidants, M-30 and green tea polyphenol. EGCG. Curr. Alzheimer Res. 2007, 4:403-411.
10. 2+-transport ATPase from synaptosomal vesicles by flavonoids. Biochim. Biophys. Acta 1983, 730:245-254.
11. Benaki D., Stathopoulou K., Leondiadis L., Ferderigos N., Pelecanou M., Mikros E. Detection of interactions of the beta-amyloid peptide with small molecules employing transferred NOEs. J. Pept. Sci. 2009, 15:435-441.
12. Bieschke J., Russ J., Friedrich R.P., Ehrnhoefer D.E., Wobst H., Neugebauer K., Wanker E.E. EGCG remodels mature alpha-synuclein and amyloid-beta fibrils and reduces cellular toxicity. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:7710-7715.
13. Bjelakovic G., Gluud L.L., Nikolova D., Bjelakovic M., Nagorni A., Gluud C. Antioxidant supplements for liver diseases. Cochrane Database Syst. Rev. 2011, 3:CD007749.
14. Boege F., Straub T., Kehr A., Boesenberg C., Christiansen K., Andersen A., Jakob F., Kohrle J. Selected novel flavones inhibit the DNA binding or the DNA religation step of eukaryotic topoisomerase I. J. Biol. Chem. 1996, 271:2262-2270.
15. Bohnen N.I., Kaufer D.I., Hendrickson R., Ivanco L.S., Lopresti B., Davis J.G., Constantine G., Mathis C.A., Moore R.Y., DeKosky S.T. Cognitive correlates of alterations in acetylcholinesterase in Alzheimer's disease. Neurosci. Lett. 2005, 380:127-132.
16. Bonfoco E., Krainc D., Ankarcrona M., Nicotera P., Lipton S.A. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-d-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:7162-7166.
17. Bonni A., Brunet A., West A.E., Datta S.R., Takasu M.A., Greenberg M.E. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science 1999, 286:1358-1362.
18. Bors W., Michel C., Stettmaier K. Structure-activity relationships governing antioxidant capacities of plant polyphenols. Methods Enzymol. 2001, 335:166-180.
19. Brown M.K., Evans J.L., Luo Y. Beneficial effects of natural antioxidants EGCG and alpha-lipoic acid on life span and age-dependent behavioral declines in Caenorhabditis elegans. Pharmacol. Biochem. Behav. 2006, 85:620-628.
20. Budd S.L., Tenneti L., Lishnak T., Lipton S.A. Mitochondrial and extramitochondrial apoptotic signaling pathways in cerebrocortical neurons. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:6161-6166.
21. Campos-Esparza M.R., Sanchez-Gomez M.V., Matute C. Molecular mechanisms of neuroprotection by two natural antioxidant polyphenols. Cell Calcium 2009, 45:358-368.
22. Camps P., Munoz-Torrero D. Tacrine-huperzine A hybrids (huprines): a new class of highly potent and selective acetylcholinesterase inhibitors of interest for the treatment of Alzheimer's disease. Mini Rev. Med. Chem. 2001, 1:163-174.
23. Cao X., Sudhof T.C. Dissection of amyloid-beta precursor protein-dependent transcriptional transactivation. J. Biol. Chem. 2004, 279:24601-24611.
24. Chakraborty S., Kumar S., Basu S. Conformational transition in the substrate binding domain of beta-secretase exploited by NMA and its implication in inhibitor recognition: BACE1-myricetin a case study. Neurochem. Int. 2011, 58:914-923.
25. Chang-Mu C., Jen-Kun L., Shing-Hwa L., Shoei-Yn L.S. Characterization of neurotoxic effects of NMDA and the novel neuroprotection by phytopolyphenols in mice. Behav. Neurosci. 2010, 124:541-553.
26. Chang H.C., Doerge D.R. Dietary genistein inactivates rat thyroid peroxidase in vivo without an apparent hypothyroid effect. Toxicol. Appl. Pharmacol. 2000, 168:244-252.
27. Chao J., Lau W.K., Huie M.J., Ho Y.S., Yu M.S., Lai C.S., Wang M., Yuen W.H., Lam W.H., Chan T.H., Chang R.C. A pro-drug of the green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG) prevents differentiated SH-SY5Y cells from toxicity induced by 6-hydroxydopamine. Neurosci. Lett. 2010, 469:360-364.
28. Checkoway H., Powers K., Smith-Weller T., Franklin G.M., Longstreth W.T., Swanson P.D. Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake. Am. J. Epidemiol. 2002, 155:732-738.
29. Chen C.M., Lin J.K., Liu S.H., Lin-Shiau S.Y. Novel regimen through combination of memantine and tea polyphenol for neuroprotection against brain excitotoxicity. J. Neurosci. Res. 2008, 86:2696-2704.
30. Chen G.J., Xu J., Lahousse S.A., Caggiano N.L., de la Monte S.M. Transient hypoxia causes Alzheimer-type molecular and biochemical abnormalities in cortical neurons: potential strategies for neuroprotection. J. Alzheimers Dis. 2003, 5:209-228.
31. Chen J., Zhou Y., Mueller-Steiner S., Chen L.F., Kwon H., Yi S., Mucke L., Gan L. SIRT1 protects against microglia-dependent amyloid-beta toxicity through inhibiting NF-kappaB signaling. J. Biol. Chem. 2005, 280:40364-40374.
32. Choi C.W., Choi Y.H., Cha M.R., Kim Y.S., Yon G.H., Hong K.S., Park W.K., Kim Y.H., Ryu S.Y. In vitro BACE-1 inhibitory activity of resveratrol oligomers from the seed extract of Paeonia lactiflora. Planta Med. 2011, 77:374-376.
33. Choi D.W., Monyer H., Giffard R.G., Goldberg M.P., Christine C.W. Acute brain injury, NMDA receptors, and hydrogen ions: observations in cortical cell cultures. Adv. Exp. Med. Biol. 1990, 268:501-504.
34. Choi Y.T., Jung C.H., Lee S.R., Bae J.H., Baek W.K., Suh M.H., Park J., Park C.W., Suh S.I. The green tea polyphenol (-)-epigallocatechin gallate attenuates beta-amyloid-induced neurotoxicity in cultured hippocampal neurons. Life Sci. 2001, 70:603-614.
35. Cirillo G., Hampel S., Klingeler R., Puoci F., Iemma F., Curcio M., Parisi O.I., Spizzirri U.G., Picci N., Leonhardt A., Ritschel M., Buchner B. Antioxidant multi-walled carbon nanotubes by free radical grafting of gallic acid: new materials for biomedical applications. J. Pharm. Pharmacol. 2011, 63:179-188.
36. Coma M., Sereno L., Da Rocha-Souto B., Scotton T.C., Espana J., Sanchez M.B., Rodriguez M., Agullo J., Guardia-Laguarta C., Garcia-Alloza M., Borrelli L.A., Clarimon J., Lleo A., Bacskai B.J., Saura C.A., Hyman B.T., Gomez-Isla T. Triflusal reduces dense-core plaque load, associated axonal alterations and inflammatory changes, and rescues cognition in a transgenic mouse model of Alzheimer's disease. Neurobiol. Dis. 2010, 38:482-491.
37. Commenges D., Scotet V., Renaud S., Jacqmin-Gadda H., Barberger-Gateau P., Dartigues J.F. Intake of flavonoids and risk of dementia. Eur. J. Epidemiol. 2000, 16:357-363.
38. Conseil G., Baubichon-Cortay H., Dayan G., Jault J.M., Barron D., Di Pietro A. Flavonoids: a class of modulators with bifunctional interactions at vicinal ATP- and steroid-binding sites on mouse P-glycoprotein. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:9831-9836.
39. Cordier, W., Steenkamp, V., 2011. Herbal remedies affecting coagulation: a review. Pharm. Biol., , in press. doi:10.3109/13880209.2011.611145.
40. Dade M.M., Schinella G.R., Fioravanti D.E., Alfiotournier H. Antioxidant and cytotoxic properties of an aqueous extract from the Argentinean plant Hedeoma multiflorum. Pharm. Biol. 2011, 49:633-639.
41. Dai Q., Borenstein A.R., Wu Y., Jackson J.C., Larson E.B. Fruit and vegetable juices and Alzheimer's disease: the Kame Project. Am. J. Med. 2006, 119:751-759.
42. Dasgupta B., Milbrandt J. Resveratrol stimulates AMP kinase activity in neurons. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:7217-7222.
43. Datta S.R., Brunet A., Greenberg M.E. Cellular survival: a play in three Akts. Genes Dev. 1999, 13:2905-2927.
44. Davis K.L., Mohs R.C., Marin D., Purohit D.P., Perl D.P., Lantz M., Austin G., Haroutunian V. Cholinergic markers in elderly patients with early signs of Alzheimer disease. JAMA 1999, 281:1401-1406.
45. Dawson V.L., Dawson T.M., London E.D., Bredt D.S., Snyder S.H. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl. Acad. Sci. U.S.A. 1991, 88:6368-6371.
46. Dekermendjian K., Kahnberg P., Witt M.R., Sterner O., Nielsen M., Liljefors T. Structure-activity relationships and molecular modeling analysis of flavonoids binding to the benzodiazepine site of the rat brain GABA(A) receptor complex. J. Med. Chem. 1999, 42:4343-4350.
47. Delclos K.B., Bucci T.J., Lomax L.G., Latendresse J.R., Warbritton A., Weis C.C., Newbold R.R. Effects of dietary genistein exposure during development on male and female CD (Sprague-Dawley) rats. Reprod. Toxicol. 2001, 15:647-663.
48. Della-Morte D., Dave K.R., DeFazio R.A., Bao Y.C., Raval A.P., Perez-Pinzon M.A. Resveratrol pretreatment protects rat brain from cerebral ischemic damage via a sirtuin 1-uncoupling protein 2 pathway. Neuroscience 2009, 159:993-1002.
49. Deprez S., Mila I., Huneau J.F., Tome D., Scalbert A. Transport of proanthocyanidin dimer, trimer, and polymer across monolayers of human intestinal epithelial Caco-2 cells. Antioxid. Redox Signal. 2001, 3:957-967.
50. Desmond D.W., Moroney J.T., Sano M., Stern Y. Incidence of dementia after ischemic stroke: results of a longitudinal study. Stroke 2002, 33:2254-2260.
51. Di Pietro A., Godinot C., Bouillant M.L., Gautheron D.C. Pig heart mitochondrial ATPase: properties of purified and membrane-bound enzyme. Effects of flavonoids. Biochimie 1975, 57:959-967.
52. Doerge D.R., Chang H.C. Inactivation of thyroid peroxidase by soy isoflavones, in vitro and in vivo. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2002, 777:269-279.
53. Doerge D.R., Sheehan D.M. Goitrogenic and estrogenic activity of soy isoflavones. Environ. Health Perspect. 2002, 110(Suppl 3):349-353.
54. Domingo D.S., Camouse M.M., Hsia A.H., Matsui M., Maes D., Ward N.L., Cooper K.D., Baron E.D. Anti-angiogenic effects of epigallocatechin-3-gallate in human skin. Int. J. Clin. Exp. Pathol. 2010, 3:705-709.
55. Donovan J.L., Manach C., Rios L., Morand C., Scalbert A., Remesy C. Procyanidins are not bioavailable in rats fed a single meal containing a grapeseed extract or the procyanidin dimer B3. Br. J. Nutr. 2002, 87:299-306.
56. Duennwald M.L., Shorter J. Countering amyloid polymorphism and drug resistance with minimal drug cocktails. Prion 2010, 4:244-251.
57. Dunnick J.K., Hailey J.R. Toxicity and carcinogenicity studies of quercetin, a natural component of foods. Fundam. Appl. Toxicol. 1992, 19:423-431.
58. Ehrnhoefer D.E., Bieschke J., Boeddrich A., Herbst M., Masino L., Lurz R., Engemann S., Pastore A., Wanker E.E. EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers. Nat. Struct. Mol. Biol. 2008, 15:558-566.
59. Ehrnhoefer D.E., Duennwald M., Markovic P., Wacker J.L., Engemann S., Roark M., Legleiter J., Marsh J.L., Thompson L.M., Lindquist S., Muchowski P.J., Wanker E.E. Green tea (-)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models. Hum. Mol. Genet. 2006, 15:2743-2751.
60. Esch F.S., Keim P.S., Beattie E.C., Blacher R.W., Culwell A.R., Oltersdorf T., McClure D., Ward P.J. Cleavage of amyloid beta peptide during constitutive processing of its precursor. Science 1990, 248:1122-1124.
61. Etcheberrigaray R., Tan M., Dewachter I., Kuiperi C., Van der Auwera I., Wera S., Qiao L., Bank B., Nelson T.J., Kozikowski A.P., Van Leuven F., Alkon D.L. Therapeutic effects of PKC activators in Alzheimer's disease transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:11141-11146.
62. Fan M.M., Raymond L.A. N-methyl-d-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease. Prog. Neurobiol. 2007, 81:272-293.
63. Ferreira A.C., Lisboa P.C., Oliveira K.J., Lima L.P., Barros I.A., Carvalho D.P. Inhibition of thyroid type 1 deiodinase activity by flavonoids. Food Chem. Toxicol. 2002, 40:913-917.
64. Fisher A. Cholinergic treatments with emphasis on m1 muscarinic agonists as potential disease-modifying agents for Alzheimer's disease. Neurotherapeutics 2008, 5:433-442.
65. Fukui M., Choi H.J., Zhu B.T. Mechanism for the protective effect of resveratrol against oxidative stress-induced neuronal death. Free Radic. Biol. Med. 2010, 49:800-813.
66. Gao Z.B., Chen X.Q., Hu G.Y. Inhibition of excitatory synaptic transmission by trans-resveratrol in rat hippocampus. Brain Res. 2006, 1111:41-47.
67. Gardana C., Canzi E., Simonetti P. The role of diet in the metabolism of daidzein by human faecal microbiota sampled from Italian volunteers. J. Nutr. Biochem. 2009, 20:940-947.
68. Ghanim H., Sia C.L., Korzeniewski K., Lohano T., Abuaysheh S., Marumganti A., Chaudhuri A., Dandona P. A resveratrol and polyphenol preparation suppresses oxidative and inflammatory stress response to a high-fat, high-carbohydrate meal. J. Clin. Endocrinol. Metab. 2011, 96:1409-1414.
69. Gotz M.E., Freyberger A., Riederer P. Oxidative stress: a role in the pathogenesis of Parkinson's disease. J. Neural Transm. Suppl. 1990, 29:241-249.
70. Gotz M.E., Kunig G., Riederer P., Youdim M.B. Oxidative stress: free radical production in neural degeneration. Pharmacol. Ther. 1994, 63:37-122.
71. Guo A.J., Xie H.Q., Choi R.C., Zheng K.Y., Bi C.W., Xu S.L., Dong T.T., Tsim K.W. Galangin, a flavonol derived from Rhizoma Alpiniae Officinarum, inhibits acetylcholinesterase activity in vitro. Chem. Biol. Interact. 2010, 187:246-248.
72. Guo Q., Zhao B., Li M., Shen S., Xin W. Studies on protective mechanisms of four components of green tea polyphenols against lipid peroxidation in synaptosomes. Biochim. Biophys. Acta 1996, 1304:210-222.
73. Guo Q., Zhao B., Shen S., Hou J., Hu J., Xin W. ESR study on the structure-antioxidant activity relationship of tea catechins and their epimers. Biochim. Biophys. Acta 1999, 1427:13-23.
74. Hafner-Bratkovic I., Gaspersic J., Smid L.M., Bresjanac M., Jerala R. Curcumin binds to the alpha-helical intermediate and to the amyloid form of prion protein - a new mechanism for the inhibition of PrP(Sc) accumulation. J. Neurochem. 2008, 104:1553-1564.
75. Hagiwara A., Hirose M., Takahashi S., Ogawa K., Shirai T., Ito N. Forestomach and kidney carcinogenicity of caffeic acid in F344 rats and C57BL/6N×C3H/HeN F1 mice. Cancer Res. 1991, 51:5655-5660.
76. Halliwell B. Reactive oxygen species and the central nervous system. J. Neurochem. 1992, 59:1609-1623.
77. Halliwell B. Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging 2001, 18:685-716.
78. Halliwell B., Zhao K., Whiteman M. The gastrointestinal tract: a major site of antioxidant action?. Free Radic. Res. 2000, 33:819-830.
79. Han Y.S., Zheng W.H., Bastianetto S., Chabot J.G., Quirion R. Neuroprotective effects of resveratrol against beta-amyloid-induced neurotoxicity in rat hippocampal neurons: involvement of protein kinase C. Br. J. Pharmacol. 2004, 141:997-1005.
80. Hanson E.S., Foot L.M., Leibold E.A. Hypoxia post-translationally activates iron-regulatory protein 2. J. Biol. Chem. 1999, 274:5047-5052.
81. Hanson E.S., Leibold E.A. Regulation of the iron regulatory proteins by reactive nitrogen and oxygen species. Gene Expr. 1999, 7:367-376.
82. Hanyu H., Asano T., Sakurai H., Tanaka Y., Takasaki M., Abe K. MR analysis of the substantia innominata in normal aging, Alzheimer disease, and other types of dementia. AJNR Am. J. Neuroradiol. 2002, 23:27-32.
83. Harikumar K.B., Aggarwal B.B. Resveratrol: a multitargeted agent for age-associated chronic diseases. Cell Cycle 2008, 7:1020-1035.
84. Harish G., Venkateshappa C., Mythri R.B., Dubey S.K., Mishra K., Singh N., Vali S., Bharath M.M. Bioconjugates of curcumin display improved protection against glutathione depletion mediated oxidative stress in a dopaminergic neuronal cell line: implications for Parkinson's disease. Bioorg. Med. Chem. 2010, 18:2631-2638.
85. Heneka M.T., O'Banion M.K. Inflammatory processes in Alzheimer's disease. J. Neuroimmunol. 2007, 184:69-91.
86. Higuchi A., Yonemitsu K., Koreeda A., Tsunenari S. Inhibitory activity of epigallocatechin gallate (EGCG) in paraquat-induced microsomal lipid peroxidation - a mechanism of protective effects of EGCg against paraquat toxicity. Toxicology 2003, 183:143-149.
87. Hirose M., Hoshiya T., Mizoguchi Y., Nakamura A., Akagi K., Shirai T. Green tea catechins enhance tumor development in the colon without effects in the lung or thyroid after pretreatment with 1,2-dimethylhydrazine or 2,2'-dihydroxy-di-n-propylnitrosamine in male F344 rats. Cancer Lett. 2001, 168:23-29.
88. Hofer T., Wenger H., Gassmann M. Oxygen sensing, HIF-1alpha stabilization and potential therapeutic strategies. Pflugers Arch. 2002, 443:503-507.
89. Hollman P.C., de Vries J.H., van Leeuwen S.D., Mengelers M.J., Katan M.B. Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am. J. Clin. Nutr. 1995, 62:1276-1282.
90. Holt R.R., Lazarus S.A., Sullards M.C., Zhu Q.Y., Schramm D.D., Hammerstone J.F., Fraga C.G., Schmitz H.H., Keen C.L. Procyanidin dimer B2 [epicatechin-(4beta-8)-epicatechin] in human plasma after the consumption of a flavanol-rich cocoa. Am. J. Clin. Nutr. 2002, 76:798-804.
91. Huang Y.H., Zhang Q.H. Genistein reduced the neural apoptosis in the brain of ovariectomised rats by modulating mitochondrial oxidative stress. Br. J. Nutr. 2010, 104:1297-1303.
92. Hudson S.A., Ecroyd H., Dehle F.C., Musgrave I.F., Carver J.A. (-)-Epigallocatechin-3-gallate (EGCG) maintains kappa-casein in its pre-fibrillar state without redirecting its aggregation pathway. J. Mol. Biol. 2009, 392:689-700.
93. Hughes C.L. Phytochemical mimicry of reproductive hormones and modulation of herbivore fertility by phytoestrogens. Environ. Health Perspect. 1988, 78:171-174.
94. Huo C., Wan S.B., Lam W.H., Li L., Wang Z., Landis-Piwowar K.R., Chen D., Dou Q.P., Chan T.H. The challenge of developing green tea polyphenols as therapeutic agents. Inflammopharmacology 2008, 16:248-252.
95. Inoue H., Akiyama S., Maeda-Yamamoto M., Nesumi A., Tanaka T., Murakami A. High-dose green tea polyphenols induce nephrotoxicity in dextran sulfate sodium-induced colitis mice by down-regulation of antioxidant enzymes and heat-shock protein expressions. Cell Stress Chaperones 2011, 16:653-662.
96. Iqbal K., Liu F., Gong C.X., Alonso Adel C., Grundke-Iqbal I. Mechanisms of tau-induced neurodegeneration. Acta Neuropathol. 2009, 118:53-69.
97. Iqbal K., Wang X., Blanchard J., Liu F., Gong C.X., Grundke-Iqbal I. Alzheimer's disease neurofibrillary degeneration: pivotal and multifactorial. Biochem. Soc. Trans. 2010, 38:962-966.
98. Ivan M., Kondo K., Yang H., Kim W., Valiando J., Ohh M., Salic A., Asara J.M., Lane W.S., Kaelin W.G. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 2001, 292:464-468.
99. 2-regulated prolyl hydroxylation. Science 2001, 292:468-472.
100. Jang J.H., Surh Y.J. Protective effect of resveratrol on beta-amyloid-induced oxidative PC12 cell death. Free Radic. Biol. Med. 2003, 34:1100-1110.
101. Jendroska K., Hoffmann O.M., Patt S. Amyloid beta peptide and precursor protein (APP) in mild and severe brain ischemia. Ann. N.Y. Acad. Sci. 1997, 826:401-405.
102. Jeon S.Y., Kwon S.H., Seong Y.H., Bae K., Hur J.M., Lee Y.Y., Suh D.Y., Song K.S. Beta-secretase (BACE1)-inhibiting stilbenoids from Smilax Rhizoma. Phytomedicine 2007, 14:403-408.
103. Jones E., Hughes R.E. Quercetin, flavonoids and the life-span of mice. Exp. Gerontol. 1982, 17:213-217.
104. Joseph J.A., Shukitt-Hale B., Brewer G.J., Weikel K.A., Kalt W., Fisher D.R. Differential protection among fractionated blueberry polyphenolic families against DA-, Abeta(42)- and LPS-induced decrements in Ca(2+) buffering in primary hippocampal cells. J. Agric. Food Chem. 2010, 58:8196-8204.
105. Joseph T.B., Wang S.W., Liu X., Kulkarni K.H., Wang J., Xu H., Hu M. Disposition of flavonoids via enteric recycling: enzyme stability affects characterization of prunetin glucuronidation across species, organs, and UGT isoforms. Mol. Pharm. 2007, 4:883-894.
106. Kalfon L., Youdim M.B., Mandel S.A. Green tea polyphenol (-)-epigallocatechin-3-gallate promotes the rapid protein kinase C- and proteasome-mediated degradation of Bad: implications for neuroprotection. J. Neurochem. 2007, 100:992-1002.
107. Kang K.S., Wen Y., Yamabe N., Fukui M., Bishop S.C., Zhu B.T. Dual beneficial effects of (-)-epigallocatechin-3-gallate on levodopa methylation and hippocampal neurodegeneration: in vitro and in vivo studies. PLoS One 2010, 5:e11951.
108. Kantengwa S., Polla B.S. Flavonoids, but not protein kinase C inhibitors, prevent stress protein synthesis during erythrophagocytosis. Biochem. Biophys. Res. Commun. 1991, 180:308-314.
109. Karuppagounder S.S., Pinto J.T., Xu H., Chen H.L., Beal M.F., Gibson G.E. Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease. Neurochem. Int. 2009, 54:111-118.
110. Kawahara M., Kuroda Y. Molecular mechanism of neurodegeneration induced by Alzheimer's beta-amyloid protein: channel formation and disruption of calcium homeostasis. Brain Res. Bull. 2000, 53:389-397.
111. Kawahara M., Kuroda Y., Arispe N., Rojas E. Alzheimer's beta-amyloid, human islet amylin, and prion protein fragment evoke intracellular free calcium elevations by a common mechanism in a hypothalamic GnRH neuronal cell line. J. Biol. Chem. 2000, 275:14077-14083.
112. Kay C.D. The future of flavonoid research. Br. J. Nutr. 2010, 104(Suppl 3):S91-S95.
113. Kelloff G.J., Crowell J.A., Hawk E.T., Steele V.E., Lubet R.A., Boone C.W., Covey J.M., Doody L.A., Omenn G.S., Greenwald P., Hong W.K., Parkinson D.R., Bagheri D., Baxter G.T., Blunden M., Doeltz M.K., Eisenhauer K.M., Johnson K., Knapp G.G., Longfellow D.G., Malone W.F., Nayfield S.G., Seifried H.E., Swall L.M., Sigman C.C. Strategy and planning for chemopreventive drug development: clinical development plans II. J. Cell. Biochem. Suppl. 1996, 26:54-71.
114. Kelsey N.A., Wilkins H.M., Linseman D.A. Nutraceutical antioxidants as novel neuroprotective agents. Molecules 2010, 15:7792-7814.
115. Kennedy D.O., Wightman E.L., Reay J.L., Lietz G., Okello E.J., Wilde A., Haskell C.F. Effects of resveratrol on cerebral blood flow variables and cognitive performance in humans: a double-blind, placebo-controlled, crossover investigation. Am. J. Clin. Nutr. 2010, 91:1590-1597.
116. Kim E.Y., Ham S.K., Shigenaga M.K., Han O. Bioactive dietary polyphenolic compounds reduce nonheme iron transport across human intestinal cell monolayers. J. Nutr. 2008, 138:1647-1651.
117. Kim H.K., Kim M., Kim S., Chung J.H. Effects of green tea polyphenol on cognitive and acetylcholinesterase activities. Biosci. Biotechnol. Biochem. 2004, 68:1977-1979.
118. Kim J.Y., Lee W.S., Kim Y.S., Curtis-Long M.J., Lee B.W., Ryu Y.B., Park K.H. Isolation of cholinesterase-inhibiting flavonoids from Morus lhou. J. Agric. Food Chem. 2011.
119. Kim S.J., Jeong H.J., Lee K.M., Myung N.Y., An N.H., Yang W.M., Park S.K., Lee H.J., Hong S.H., Kim H.M., Um J.Y. Epigallocatechin-3-gallate suppresses NF-kappaB activation and phosphorylation of p38 MAPK and JNK in human astrocytoma U373MG cells. J. Nutr. Biochem. 2007, 18:587-596.
120. Kitisripanya N., Saparpakorn P., Wolschann P., Hannongbua S. Binding of huperzine A and galanthamine to acetylcholinesterase, based on ONIOM method. Nanomedicine 2011, 7:60-68.
121. Klein J.C., Eggers C., Kalbe E., Weisenbach S., Hohmann C., Vollmar S., Baudrexel S., Diederich N.J., Heiss W.D., Hilker R. Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo. Neurology 2010, 74:885-892.
122. Koh S.H., Lee S.M., Kim H.Y., Lee K.Y., Lee Y.J., Kim H.T., Kim J., Kim M.H., Hwang M.S., Song C., Yang K.W., Lee K.W., Kim S.H., Kim O.H. The effect of epigallocatechin gallate on suppressing disease progression of ALS model mice. Neurosci. Lett. 2006, 395:103-107.
123. Krikorian R., Nash T.A., Shidler M.D., Shukitt-Hale B., Joseph J.A. Concord grape juice supplementation improves memory function in older adults with mild cognitive impairment. Br. J. Nutr. 2010, 103:730-734.
124. Ksiezak-Reding, H., Ho, L., Santa-Maria, I., Diaz-Ruiz, C., Wang, J., Pasinetti, G.M., 2010. Ultrastructural alterations of Alzheimer's disease paired helical filaments by grape seed-derived polyphenols. Neurobiol. Aging, , in press. doi:10.1016/j.neurobiolaging.2010.11.006.
125. Kumar P., Padi S.S., Naidu P.S., Kumar A. Possible neuroprotective mechanisms of curcumin in attenuating 3-nitropropionic acid-induced neurotoxicity. Methods Find. Exp. Clin. Pharmacol. 2007, 29:19-25.
126. Kwak H.M., Jeon S.Y., Sohng B.H., Kim J.G., Lee J.M., Lee K.B., Jeong H.H., Hur J.M., Kang Y.H., Song K.S. beta-Secretase (BACE1) inhibitors from pomegranate (Punica granatum) husk. Arch. Pharm. Res. 2005, 28:1328-1332.
127. Lafon-Cazal M., Pietri S., Culcasi M., Bockaert J. NMDA-dependent superoxide production and neurotoxicity. Nature 1993, 364:535-537.
128. Lahiri D.K., Rogers J.T., Greig N.H., Sambamurti K. Rationale for the development of cholinesterase inhibitors as anti-Alzheimer agents. Curr. Pharm. Des. 2004, 10:3111-3119.
129. Lambert J.D., Sang S., Hong J., Kwon S.J., Lee M.J., Ho C.T., Yang C.S. Peracetylation as a means of enhancing in vitro bioactivity and bioavailability of epigallocatechin-3-gallate. Drug Metab. Dispos. 2006, 34:2111-2116.
130. Larner A.J. Cholinesterase inhibitors: beyond Alzheimer's disease. Expert Rev. Neurother. 2010, 10:1699-1705.
131. Lee H., Bae J.H., Lee S.R. Protective effect of green tea polyphenol EGCG against neuronal damage and brain edema after unilateral cerebral ischemia in gerbils. J. Neurosci. Res. 2004, 77:892-900.
132. Lee H.H., Lin C.T., Yang L.L. Neuroprotection and free radical scavenging effects of Osmanthus fragrans. J. Biomed. Sci. 2007, 14:819-827.
133. Lee J.W., Lee Y.K., Ban J.O., Ha T.Y., Yun Y.P., Han S.B., Oh K.W., Hong J.T. Green tea (-)-epigallocatechin-3-gallate inhibits beta-amyloid-induced cognitive dysfunction through modification of secretase activity via inhibition of ERK and NF-kappaB pathways in mice. J. Nutr. 2009, 139:1987-1993.
134. Lemus-Molina Y., Sanchez-Gomez M.V., Delgado-Hernandez R., Matute C. Mangifera indica L. extract attenuates glutamate-induced neurotoxicity on rat cortical neurons. Neurotoxicology 2009, 30:1053-1058.
135. Levey A.I., Kitt C.A., Simonds W.F., Price D.L., Brann M.R. Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies. J. Neurosci. 1991, 11:3218-3226.
136. Levites Y., Amit T., Mandel S., Youdim M.B. Neuroprotection and neurorescue against Abeta toxicity and PKC-dependent release of nonamyloidogenic soluble precursor protein by green tea polyphenol (-)-epigallocatechin-3-gallate. FASEB J. 2003, 17:952-954.
137. Levites Y., Amit T., Youdim M.B., Mandel S. Involvement of protein kinase C activation and cell survival/cell cycle genes in green tea polyphenol (-)-epigallocatechin 3-gallate neuroprotective action. J. Biol. Chem. 2002, 277:30574-30580.
138. Levites Y., Weinreb O., Maor G., Youdim M.B., Mandel S. Green tea polyphenol (-)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration. J. Neurochem. 2001, 78:1073-1082.
139. Levites Y., Youdim M.B., Maor G., Mandel S. Attenuation of 6-hydroxydopamine (6-OHDA)-induced nuclear factor-kappaB (NF-kappaB) activation and cell death by tea extracts in neuronal cultures. Biochem. Pharmacol. 2002, 63:21-29.
140. Levy M., Porat Y., Bacharach E., Shalev D.E., Gazit E. Phenolsulfonphthalein, but not phenolphthalein, inhibits amyloid fibril formation: implications for the modulation of amyloid self-assembly. Biochemistry 2008, 47:5896-5904.
141. Li J., Wu H.M., Zhou R.L., Liu G.J., Dong B.R. Huperzine A for Alzheimer's disease. Cochrane Database Syst. Rev. 2008, CD005592.
142. Li M.H., Jang J.H., Sun B., Surh Y.J. Protective effects of oligomers of grape seed polyphenols against beta-amyloid-induced oxidative cell death. Ann. N.Y. Acad. Sci. 2004, 1030:317-329.
143. Liang Y.Q., Tang X.C. Comparative effects of huperzine A, donepezil and rivastigmine on cortical acetylcholine level and acetylcholinesterase activity in rats. Neurosci. Lett. 2004, 361:56-59.
144. Lilja J.J., Kivisto K.T., Backman J.T., Neuvonen P.J. Effect of grapefruit juice dose on grapefruit juice-triazolam interaction: repeated consumption prolongs triazolam half-life. Eur. J. Clin. Pharmacol. 2000, 56:411-415.
145. Lin H.J., Lai C.C., Lee Chao P.D., Fan S.S., Tsai Y., Huang S.Y., Wan L., Tsai F.J. Aloe-emodin metabolites protected N-methyl-d-aspartate-treated retinal ganglion cells by Cu-Zn superoxide dismutase. J. Ocul. Pharmacol. Ther. 2007, 23:152-171.
146. Lin M.S., Hung K.S., Chiu W.T., Sun Y.Y., Tsai S.H., Lin J.W., Lee Y.H. Curcumin enhances neuronal survival in N-methyl-d-aspartic acid toxicity by inducing RANTES expression in astrocytes via PI-3K and MAPK signaling pathways. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35:931-938.
147. Lin M.T., Beal M.F. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 2006, 443:787-795.
148. Lin Y.S., Tsai Y.J., Tsay J.S., Lin J.K. Factors affecting the levels of tea polyphenols and caffeine in tea leaves. J. Agric. Food Chem. 2003, 51:1864-1873.
149. Lipton S.A. Pathologically-activated therapeutics for neuroprotection: mechanism of NMDA receptor block by memantine and S-nitrosylation. Curr. Drug Targets 2007, 8:621-632.
150. Lipton S.A., Choi Y.B., Pan Z.H., Lei S.Z., Chen H.S., Sucher N.J., Loscalzo J., Singel D.J., Stamler J.S. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 1993, 364:626-632.
151. Lipton S.A., Rosenberg P.A. Excitatory amino acids as a final common pathway for neurologic disorders. N. Engl. J. Med. 1994, 330:613-622.
152. Liu Y.Q., Xin T.R., Liang J.J., Wang W.M., Zhang Y.Y. Memory performance, brain excitatory amino acid and acetylcholinesterase activity of chronically aluminum exposed mice in response to soy isoflavones treatment. Phytother. Res. 2010, 24:1451-1456.
153. Lu J., Zhang K., Chen S., Wen W. Grape seed extract inhibits VEGF expression via reducing HIF-1alpha protein expression. Carcinogenesis 2009, 30:636-644.
154. Lu J.H., Guo J., Yang W.H. Effects of green tea polyphenol on the behaviour of Alzheimer' s disease like mice induced by d-galactose and Abeta 25-35. Zhong Yao Cai 2006, 29:352-354.
155. Lu K.T., Ko M.C., Chen B.Y., Huang J.C., Hsieh C.W., Lee M.C., Chiou R.Y., Wung B.S., Peng C.H., Yang Y.L. Neuroprotective effects of resveratrol on MPTP-induced neuron loss mediated by free radical scavenging. J. Agric. Food Chem. 2008, 56:6910-6913.
156. Ma Q., Kim E.Y., Han O. Bioactive dietary polyphenols decrease heme iron absorption by decreasing basolateral iron release in human intestinal Caco-2 cells. J. Nutr. 2010, 140:1117-1121.
157. Ma X., Tan C., Zhu D., Gang D.R., Xiao P. Huperzine A from Huperzia species - an ethnopharmacolgical review. J. Ethnopharmacol. 2007, 113:15-34.
158. Maher P., Dargusch R., Bodai L., Gerard P.E., Purcell J.M., Marsh J.L. ERK activation by the polyphenols fisetin and resveratrol provides neuroprotection in multiple models of Huntington's disease. Hum. Mol. Genet. 2011, 20:261-270.
159. Man S.C., Durairajan S.S., Kum W.F., Lu J.H., Huang J.D., Cheng C.F., Chung V., Xu M., Li M. Systematic review on the efficacy and safety of herbal medicines for Alzheimer's disease. J. Alzheimers Dis. 2008, 14:209-223.
160. Manach C., Williamson G., Morand C., Scalbert A., Remesy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am. J. Clin. Nutr. 2005, 81:230S-242S.
161. Manczak M., Mao P., Calkins M.J., Cornea A., Reddy A.P., Murphy M.P., Szeto H.H., Park B., Reddy P.H. Mitochondria-targeted antioxidants protect against amyloid-beta toxicity in Alzheimer's disease neurons. J. Alzheimers Dis. 2010, 20(Suppl. 2):S609-S631.
162. Mandel S., Amit T., Reznichenko L., Weinreb O., Youdim M.B. Green tea catechins as brain-permeable, natural iron chelators-antioxidants for the treatment of neurodegenerative disorders. Mol. Nutr. Food Res. 2006, 50:229-234.
163. Mandel S., Maor G., Youdim M.B. Iron and alpha-synuclein in the substantia nigra of MPTP-treated mice: effect of neuroprotective drugs R-apomorphine and green tea polyphenol (-)-epigallocatechin-3-gallate. J. Mol. Neurosci. 2004, 24:401-416.
164. Mandel S., Weinreb O., Amit T., Youdim M.B. Cell signaling pathways in the neuroprotective actions of the green tea polyphenol (-)-epigallocatechin-3-gallate: implications for neurodegenerative diseases. J. Neurochem. 2004, 88:1555-1569.
165. Mandel S.A., Avramovich-Tirosh Y., Reznichenko L., Zheng H., Weinreb O., Amit T., Youdim M.B. Multifunctional activities of green tea catechins in neuroprotection. Modulation of cell survival genes, iron-dependent oxidative stress and PKC signaling pathway. Neurosignals 2005, 14:46-60.
166. Marambaud P., Zhao H., Davies P. Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides. J. Biol. Chem. 2005, 280:37377-37382.
167. Martin D., Salinas M., Lopez-Valdaliso R., Serrano E., Recuero M., Cuadrado A. Effect of the Alzheimer amyloid fragment Abeta(25-35) on Akt/PKB kinase and survival of PC12 cells. J. Neurochem. 2001, 78:1000-1008.
168. Mattson M.P. Evidence for the involvement of protein kinase C in neurodegenerative changes in cultured human cortical neurons. Exp. Neurol. 1991, 112:95-103.
169. Mattson M.P. Pathways towards and away from Alzheimer's disease. Nature 2004, 430:631-639.
170. Medina J.H., Viola H., Wolfman C., Marder M., Wasowski C., Calvo D., Paladini A.C. Overview - flavonoids: a new family of benzodiazepine receptor ligands. Neurochem. Res. 1997, 22:419-425.
171. Mendez M.A., Anthony M.S., Arab L. Soy-based formulae and infant growth and development: a review. J. Nutr. 2002, 132:2127-2130.
172. Mennen L.I., Walker R., Bennetau-Pelissero C., Scalbert A. Risks and safety of polyphenol consumption. Am. J. Clin. Nutr. 2005, 81:326S-329S.
173. Mielke K., Herdegen T. JNK and p38 stresskinases - degenerative effectors of signal-transduction-cascades in the nervous system. Prog. Neurobiol. 2000, 61:45-60.
174. Min B.S., Cuong T.D., Lee J.S., Shin B.S., Woo M.H., Hung T.M. Cholinesterase inhibitors from Cleistocalyx operculatus buds. Arch. Pharm. Res. 2010, 33:1665-1670.
175. Miyake Y., Shimoi K., Kumazawa S., Yamamoto K., Kinae N., Osawa T. Identification and antioxidant activity of flavonoid metabolites in plasma and urine of eriocitrin-treated rats. J. Agric. Food Chem. 2000, 48:3217-3224.
176. Morand C., Manach C., Crespy V., Remesy C. Quercetin 3-O-beta-glucoside is better absorbed than other quercetin forms and is not present in rat plasma. Free Radic. Res. 2000, 33:667-676.
177. Morel I., Lescoat G., Cogrel P., Sergent O., Pasdeloup N., Brissot P., Cillard P., Cillard J. Antioxidant and iron-chelating activities of the flavonoids catechin, quercetin and diosmetin on iron-loaded rat hepatocyte cultures. Biochem. Pharmacol. 1993, 45:13-19.
178. Mythri R.B., Harish G., Dubey S.K., Misra K., Bharath M.M. Glutamoyl diester of the dietary polyphenol curcumin offers improved protection against peroxynitrite-mediated nitrosative stress and damage of brain mitochondria in vitro: implications for Parkinson's disease. Mol. Cell. Biochem. 2011, 347:135-143.
179. Nanjo F., Goto K., Seto R., Suzuki M., Sakai M., Hara Y. Scavenging effects of tea catechins and their derivatives on 1,1-diphenyl-2-picrylhydrazyl radical. Free Radic. Biol. Med. 1996, 21:895-902.
180. Nanjo F., Mori M., Goto K., Hara Y. Radical scavenging activity of tea catechins and their related compounds. Biosci. Biotechnol. Biochem. 1999, 63:1621-1623.
181. Ng T.P., Feng L., Niti M., Kua E.H., Yap K.B. Tea consumption and cognitive impairment and decline in older Chinese adults. Am. J. Clin. Nutr. 2008, 88:224-231.
182. Nunan J., Small D.H. Regulation of APP cleavage by alpha-, beta- and gamma-secretases. FEBS Lett. 2000, 483:6-10.
183. Obregon D.F., Rezai-Zadeh K., Bai Y., Sun N., Hou H., Ehrhart J., Zeng J., Mori T., Arendash G.W., Shytle D., Town T., Tan J. ADAM10 activation is required for green tea (-)-epigallocatechin-3-gallate-induced alpha-secretase cleavage of amyloid precursor protein. J. Biol. Chem. 2006, 281:16419-16427.
184. Ogunshola O.O., Antoniou X. Contribution of hypoxia to Alzheimer's disease: is HIF-1alpha a mediator of neurodegeneration?. Cell. Mol. Life Sci. 2009, 66:3555-3563.
185. Ogura H., Kosasa T., Kuriya Y., Yamanishi Y. Comparison of inhibitory activities of donepezil and other cholinesterase inhibitors on acetylcholinesterase and butyrylcholinesterase in vitro. Methods Find. Exp. Clin. Pharmacol. 2000, 22:609-613.
186. Okawara M., Katsuki H., Kurimoto E., Shibata H., Kume T., Akaike A. Resveratrol protects dopaminergic neurons in midbrain slice culture from multiple insults. Biochem. Pharmacol. 2007, 73:550-560.
187. Ono K., Hasegawa K., Naiki H., Yamada M. Anti-amyloidogenic activity of tannic acid and its activity to destabilize Alzheimer's beta-amyloid fibrils in vitro. Biochim. Biophys. Acta 2004, 1690:193-202.
188. Ono K., Yoshiike Y., Takashima A., Hasegawa K., Naiki H., Yamada M. Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease. J. Neurochem. 2003, 87:172-181.
189. Ortega-Arellano H.F., Jimenez-Del-Rio M., Velez-Pardo C. Life span and locomotor activity modification by glucose and polyphenols in Drosophila melanogaster chronically exposed to oxidative stress-stimuli: implications in Parkinson's disease. Neurochem. Res. 2011, 36:1073-1086.
190. Ossowska K., Smialowska M., Kuter K., Wieronska J., Zieba B., Wardas J., Nowak P., Dabrowska J., Bortel A., Biedka I., Schulze G., Rommelspacher H. Degeneration of dopaminergic mesocortical neurons and activation of compensatory processes induced by a long-term paraquat administration in rats: implications for Parkinson's disease. Neuroscience 2006, 141:2155-2165.
191. Pallas M., Casadesus G., Smith M.A., Coto-Montes A., Pelegri C., Vilaplana J., Camins A. Resveratrol and neurodegenerative diseases: activation of SIRT1 as the potential pathway towards neuroprotection. Curr. Neurovasc. Res. 2009, 6:70-81.
192. Pannala A.S., Rice-Evans C.A., Halliwell B., Singh S. Inhibition of peroxynitrite-mediated tyrosine nitration by catechin polyphenols. Biochem. Biophys. Res. Commun. 1997, 232:164-168.
193. Papandreou M.A., Dimakopoulou A., Linardaki Z.I., Cordopatis P., Klimis-Zacas D., Margarity M., Lamari F.N. Effect of a polyphenol-rich wild blueberry extract on cognitive performance of mice, brain antioxidant markers and acetylcholinesterase activity. Behav. Brain Res. 2009, 198:352-358.
194. Park J.W., Jang Y.H., Kim J.M., Lee H., Park W.K., Lim M.B., Chu Y.K., Lo E.H., Lee S.R. Green tea polyphenol (-)-epigallocatechin gallate reduces neuronal cell damage and up-regulation of MMP-9 activity in hippocampal CA1 and CA2 areas following transient global cerebral ischemia. J. Neurosci. Res. 2009, 87:567-575.
195. Peng Y., Jiang L., Lee D.Y., Schachter S.C., Ma Z., Lemere C.A. Effects of huperzine A on amyloid precursor protein processing and beta-amyloid generation in human embryonic kidney 293 APP Swedish mutant cells. J. Neurosci. Res. 2006, 84:903-911.
196. Peng Y., Lee D.Y., Jiang L., Ma Z., Schachter S.C., Lemere C.A. Huperzine A regulates amyloid precursor protein processing via protein kinase C and mitogen-activated protein kinase pathways in neuroblastoma SK-N-SH cells over-expressing wild type human amyloid precursor protein 695. Neuroscience 2007, 150:386-395.
197. Perry E.K., Tomlinson B.E., Blessed G., Bergmann K., Gibson P.H., Perry R.H. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br. Med. J. 1978, 2:1457-1459.
198. Possemiers S., Bolca S., Verstraete W., Heyerick A. The intestinal microbiome: a separate organ inside the body with the metabolic potential to influence the bioactivity of botanicals. Fitoterapia 2011, 82:53-66.
199. Ramos S. Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention. J. Nutr. Biochem. 2007, 18:427-442.
200. Rastmanesh R. High polyphenol, low probiotic diet for weight loss because of intestinal microbiota interaction. Chem. Biol. Interact. 2011, 189:1-8.
201. Ratcliffe P.J., O'Rourke J.F., Maxwell P.H., Pugh C.W. Oxygen sensing, hypoxia-inducible factor-1 and the regulation of mammalian gene expression. J. Exp. Biol. 1998, 201:1153-1162.
202. Ray B., Bisht S., Maitra A., Lahiri D.K. Neuroprotective and neurorescue effects of a novel polymeric nanoparticle formulation of curcumin (NanoCurc) in the neuronal cell culture and animal model: implications for Alzheimer's disease. J. Alzheimers Dis. 2011, 23:61-77.
203. Reddy P.H. Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer's disease. J. Neurochem. 2006, 96:1-13.
204. 2. Gen. Pharmacol. 1997, 29:847-857.
205. Rezg R., Mornagui B., El-Fazaa S., Gharbi N. Caffeic acid attenuates malathion induced metabolic disruption in rat liver, involvement of acetylcholinesterase activity. Toxicology 2008, 250:27-31.
206. Reznichenko L., Amit T., Zheng H., Avramovich-Tirosh Y., Youdim M.B., Weinreb O., Mandel S. Reduction of iron-regulated amyloid precursor protein and beta-amyloid peptide by (-)-epigallocatechin-3-gallate in cell cultures: implications for iron chelation in Alzheimer's disease. J. Neurochem. 2006, 97:527-536.
207. Rice-Evans C.A., Miller N.J., Paganga G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic. Biol. Med. 1996, 20:933-956.
208. Riederer P., Sofic E., Rausch W.D., Schmidt B., Reynolds G.P., Jellinger K., Youdim M.B. Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J. Neurochem. 1989, 52:515-520.
209. Ritz M.F., Ratajczak P., Curin Y., Cam E., Mendelowitsch A., Pinet F., Andriantsitohaina R. Chronic treatment with red wine polyphenol compounds mediates neuroprotection in a rat model of ischemic cerebral stroke. J. Nutr. 2008, 138:519-525.
210. Riviere C., Delaunay J.C., Immel F., Cullin C., Monti J.P. The polyphenol piceid destabilizes preformed amyloid fibrils and oligomers in vitro: hypothesis on possible molecular mechanisms. Neurochem. Res. 2009, 34:1120-1128.
211. Riviere C., Richard T., Quentin L., Krisa S., Merillon J.M., Monti J.P. Inhibitory activity of stilbenes on Alzheimer's beta-amyloid fibrils in vitro. Bioorg. Med. Chem. 2007, 15:1160-1167.
212. Riviere C., Richard T., Vitrac X., Merillon J.M., Valls J., Monti J.P. New polyphenols active on beta-amyloid aggregation. Bioorg. Med. Chem. Lett. 2008, 18:828-831.
213. Roberson E.D., Mucke L. 100 years and counting: prospects for defeating Alzheimer's disease. Science 2006, 314:781-784.
214. Rodgers E.E., Theibert A.B. Functions of PI 3-kinase in development of the nervous system. Int. J. Dev. Neurosci. 2002, 20:187-197.
215. Romeo L., Intrieri M., D'Agata V., Mangano N.G., Oriani G., Ontario M.L., Scapagnini G. The major green tea polyphenol, (-)-epigallocatechin-3-gallate, induces heme oxygenase in rat neurons and acts as an effective neuroprotective agent against oxidative stress. J. Am. Coll. Nutr. 2009, 28(Suppl):492S-499S.
216. Rosenblat M., Belinky P., Vaya J., Levy R., Hayek T., Coleman R., Merchav S., Aviram M. Macrophage enrichment with the isoflavan glabridin inhibits NADPH oxidase-induced cell-mediated oxidation of low density lipoprotein. A possible role for protein kinase C. J. Biol. Chem. 1999, 274:13790-13799.
217. Rosengarten B., Dannhardt V., Burr O., Pohler M., Rosengarten S., Oechsner M., Reuter I. Neurovascular coupling in Parkinson's disease patients: effects of dementia and acetylcholinesterase inhibitor treatment. J. Alzheimers Dis. 2010, 22:415-421.
218. Rosi S., Ramirez-Amaya V., Hauss-Wegrzyniak B., Wenk G.L. Chronic brain inflammation leads to a decline in hippocampal NMDA-R1 receptors. J. Neuroinflamm. 2004, 1:12.
219. Sabarinathan D., Mahalakshmi P., Vanisree A.J. Naringenin, a flavanone inhibits the proliferation of cerebrally implanted C6 glioma cells in rats. Chem. Biol. Interact. 2011, 189:26-36.
220. Sakata Y., Zhuang H., Kwansa H., Koehler R.C., Dore S. Resveratrol protects against experimental stroke: putative neuroprotective role of heme oxygenase 1. Exp. Neurol. 2010, 224:325-329.
221. Salah N., Miller N.J., Paganga G., Tijburg L., Bolwell G.P., Rice-Evans C. Polyphenolic flavanols as scavengers of aqueous phase radicals and as chain-breaking antioxidants. Arch. Biochem. Biophys. 1995, 322:339-346.
222. Savaskan E., Olivieri G., Meier F., Seifritz E., Wirz-Justice A., Muller-Spahn F. Red wine ingredient resveratrol protects from beta-amyloid neurotoxicity. Gerontology 2003, 49:380-383.
223. Scalbert A., Morand C., Manach C., Remesy C. Absorption and metabolism of polyphenols in the gut and impact on health. Biomed. Pharmacother. 2002, 56:276-282.
224. Scalbert A., Williamson G. Dietary intake and bioavailability of polyphenols. J. Nutr. 2000, 130:2073S-2085S.
225. Schilter B., Andersson C., Anton R., Constable A., Kleiner J., O'Brien J., Renwick A.G., Korver O., Smit F., Walker R. Guidance for the safety assessment of botanicals and botanical preparations for use in food and food supplements. Food Chem. Toxicol. 2003, 41:1625-1649.
226. Selkoe D.J. The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol. 1998, 8:447-453.
227. Selkoe D.J. Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 2001, 81:741-766.
228. 2 homeostasis. Curr. Opin. Genet. Dev. 1998, 8:588-594.
229. Sharpe R.M., Franks S. Environment, lifestyle and infertility - an inter-generational issue. Nat. Cell Biol. 2002, 4(Suppl.):s33-s40.
230. Shi J., Yang S.H., Stubley L., Day A.L., Simpkins J.W. Hypoperfusion induces overexpression of beta-amyloid precursor protein mRNA in a focal ischemic rodent model. Brain Res. 2000, 853:1-4.
231. Shim S.S., Hammonds M.D., Kee B.S. Potentiation of the NMDA receptor in the treatment of schizophrenia: focused on the glycine site. Eur. Arch. Psychiatry Clin. Neurosci. 2008, 258:16-27.
232. Shimmyo Y., Kihara T., Akaike A., Niidome T., Sugimoto H. Flavonols and flavones as BACE-1 inhibitors: structure-activity relationship in cell-free, cell-based and in silico studies reveal novel pharmacophore features. Biochim. Biophys. Acta 2008, 1780:819-825.
233. Shimmyo Y., Kihara T., Akaike A., Niidome T., Sugimoto H. Multifunction of myricetin on A beta: neuroprotection via a conformational change of A beta and reduction of A beta via the interference of secretases. J. Neurosci. Res. 2008, 86:368-377.
234. Shirai M., Moon J.H., Tsushida T., Terao J. Inhibitory effect of a quercetin metabolite, quercetin 3-O-beta-d-glucuronide, on lipid peroxidation in liposomal membranes. J. Agric. Food Chem. 2001, 49:5602-5608.
235. Singh M., Arseneault M., Sanderson T., Murthy V., Ramassamy C. Challenges for research on polyphenols from foods in Alzheimer's disease: bioavailability, metabolism, and cellular and molecular mechanisms. J. Agric. Food Chem. 2008, 56:4855-4873.
236. Smith A., Giunta B., Bickford P.C., Fountain M., Tan J., Shytle R.D. Nanolipidic particles improve the bioavailability and alpha-secretase inducing ability of epigallocatechin-3-gallate (EGCG) for the treatment of Alzheimer's disease. Int. J. Pharm. 2010, 389:207-212.
237. Soucek T., Cumming R., Dargusch R., Maher P., Schubert D. The regulation of glucose metabolism by HIF-1 mediates a neuroprotective response to amyloid beta peptide. Neuron 2003, 39:43-56.
238. Sousa T., Paterson R., Moore V., Carlsson A., Abrahamsson B., Basit A.W. The gastrointestinal microbiota as a site for the biotransformation of drugs. Int. J. Pharm. 2008, 363:1-25.
239. Spencer J.P., Abd El Mohsen M.M., Minihane A.M., Mathers J.C. Biomarkers of the intake of dietary polyphenols: strengths, limitations and application in nutrition research. Br. J. Nutr. 2008, 99:12-22.
240. Spencer J.P., Rice-Evans C., Williams R.J. Modulation of pro-survival Akt/protein kinase B and ERK1/2 signaling cascades by quercetin and its in vivo metabolites underlie their action on neuronal viability. J. Biol. Chem. 2003, 278:34783-34793.
241. Spencer J.P., Schroeter H., Crossthwaithe A.J., Kuhnle G., Williams R.J., Rice-Evans C. Contrasting influences of glucuronidation and O-methylation of epicatechin on hydrogen peroxide-induced cell death in neurons and fibroblasts. Free Radic. Biol. Med. 2001, 31:1139-1146.
242. Spencer J.P., Schroeter H., Rechner A.R., Rice-Evans C. Bioavailability of flavan-3-ols and procyanidins: gastrointestinal tract influences and their relevance to bioactive forms in vivo. Antioxid. Redox Signal. 2001, 3:1023-1039.
243. Srividhya R., Jyothilakshmi V., Arulmathi K., Senthilkumaran V., Kalaiselvi P. Attenuation of senescence-induced oxidative exacerbations in aged rat brain by (-)-epigallocatechin-3-gallate. Int. J. Dev. Neurosci. 2008, 26:217-223.
244. Suganuma M., Okabe S., Oniyama M., Tada Y., Ito H., Fujiki H. Wide distribution of [3H] (-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue. Carcinogenesis 1998, 19:1771-1776.
245. Sun Q.Q., Xu S.S., Pan J.L., Guo H.M., Cao W.Q. Huperzine-A capsules enhance memory and learning performance in 34 pairs of matched adolescent students. Zhongguo Yao Li Xue Bao 1999, 20:601-603.
246. Taniguchi S., Suzuki N., Masuda M., Hisanaga S., Iwatsubo T., Goedert M., Hasegawa M. Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins. J. Biol. Chem. 2005, 280:7614-7623.
247. Tanzi R.E., Bertram L. Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell 2005, 120:545-555.
248. Teipel S.J., Flatz W.H., Heinsen H., Bokde A.L., Schoenberg S.O., Stockel S., Dietrich O., Reiser M.F., Moller H.J., Hampel H. Measurement of basal forebrain atrophy in Alzheimer's disease using MRI. Brain 2005, 128:2626-2644.
249. Temme E.H., Van Hoydonck P.G. Tea consumption and iron status. Eur. J. Clin. Nutr. 2002, 56:379-386.
250. Terao J., Yamaguchi S., Shirai M., Miyoshi M., Moon J.H., Oshima S., Inakuma T., Tsushida T., Kato Y. Protection by quercetin and quercetin 3-O-beta-d-glucuronide of peroxynitrite-induced antioxidant consumption in human plasma low-density lipoprotein. Free Radic. Res. 2001, 35:925-931.
251. Terzuoli E., Donnini S., Giachetti A., Iniguez M.A., Fresno M., Melillo G., Ziche M. Inhibition of hypoxia inducible factor-1alpha by dihydroxyphenylethanol, a product from olive oil, blocks microsomal prostaglandin-E synthase-1/vascular endothelial growth factor expression and reduces tumor angiogenesis. Clin. Cancer Res. 2010, 16:4207-4216.
252. Tesch G.H., Lim A.K. Recent insights into diabetic renal injury from the db/db mouse model of type 2 diabetic nephropathy. Am. J. Physiol. Renal Physiol. 2011, 300:F301-F310.
253. Thomas R., Kim M.H. Epigallocatechin gallate inhibits HIF-1alpha degradation in prostate cancer cells. Biochem. Biophys. Res. Commun. 2005, 334:543-548.
254. Thompson M., Williams C.R., Elliot G.E. Stability of flavonoid complexes of copper(II) and flavonoid antioxidant activity. Anal. Chim. Acta 1976, 85:375-381.
255. Tota S., Awasthi H., Kamat P.K., Nath C., Hanif K. Protective effect of quercetin against intracerebral streptozotocin induced reduction in cerebral blood flow and impairment of memory in mice. Behav. Brain Res. 2010, 209:73-79.
256. Tu S.H., Ku C.Y., Ho C.T., Chen C.S., Huang C.S., Lee C.H., Chen L.C., Pan M.H., Chang H.W., Chang C.H., Chang Y.J., Wei P.L., Wu C.H., Ho Y.S. Tea polyphenol (-)-epigallocatechin-3-gallate inhibits nicotine- and estrogen-induced alpha9-nicotinic acetylcholine receptor upregulation in human breast cancer cells. Mol. Nutr. Food Res. 2011, 55:455-466.
257. Ursini F., Maiorino M., Morazzoni P., Roveri A., Pifferi G. A novel antioxidant flavonoid (IdB 1031) affecting molecular mechanisms of cellular activation. Free Radic. Biol. Med. 1994, 16:547-553.
258. van Acker S.A., van den Berg D.J., Tromp M.N., Griffioen D.H., van Bennekom W.P., van der Vijgh W.J., Bast A. Structural aspects of antioxidant activity of flavonoids. Free Radic. Biol. Med. 1996, 20:331-342.
259. van het Hof K.H., Wiseman S.A., Yang C.S., Tijburg L.B. Plasma and lipoprotein levels of tea catechins following repeated tea consumption. Proc. Soc. Exp. Biol. Med. 1999, 220:203-209.
260. Vauzour D., Vafeiadou K., Rice-Evans C., Williams R.J., Spencer J.P. Activation of pro-survival Akt and ERK1/2 signalling pathways underlie the anti-apoptotic effects of flavanones in cortical neurons. J. Neurochem. 2007, 103:1355-1367.
261. Veronese M.L., Gillen L.P., Burke J.P., Dorval E.P., Hauck W.W., Pequignot E., Waldman S.A., Greenberg H.E. Exposure-dependent inhibition of intestinal and hepatic CYP3A4 in vivo by grapefruit juice. J. Clin. Pharmacol. 2003, 43:831-839.
262. Vingtdeux V., Giliberto L., Zhao H., Chandakkar P., Wu Q., Simon J.E., Janle E.M., Lobo J., Ferruzzi M.G., Davies P., Marambaud P. AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-beta peptide metabolism. J. Biol. Chem. 2010, 285:9100-9113.
263. Vislocky L.M., Fernandez M.L. Biomedical effects of grape products. Nutr. Rev. 2010, 68:656-670.
264. Wallin A.K., Blennow K., Andreasen N., Minthon L. CSF biomarkers for Alzheimer's Disease: levels of beta-amyloid, tau, phosphorylated tau relate to clinical symptoms and survival. Dement. Geriatr. Cogn. Disord. 2006, 21:131-138.
265. Wang B.S., Wang H., Wei Z.H., Song Y.Y., Zhang L., Chen H.Z. Efficacy and safety of natural acetylcholinesterase inhibitor huperzine A in the treatment of Alzheimer's disease: an updated meta-analysis. J. Neural. Transm. 2009, 116:457-465.
266. Wang C.Y., Zheng W., Wang T., Xie J.W., Wang S.L., Zhao B.L., Teng W.P., Wang Z.Y. Huperzine A activates Wnt/beta-catenin signaling and enhances the nonamyloidogenic pathway in an Alzheimer transgenic mouse model. Neuropsychopharmacology 2011, 36:1073-1089.
267. Wang G.L., Semenza G.L. General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:4304-4308.
268. Wang H., Tang X.C. Anticholinesterase effects of huperzine A, E2020, and tacrine in rats. Zhongguo Yao Li Xue Bao 1998, 19:27-30.
269. Wang J., Pantopoulos K. The pathway for IRP2 degradation involving 2-oxoglutarate-dependent oxygenase(s) does not require the E3 ubiquitin ligase activity of pVHL. Biochim. Biophys. Acta 2005, 1743:79-85.
270. Wang J., Pfleger C.M., Friedman L., Vittorino R., Zhao W., Qian X., Conley L., Ho L., Pasinetti G.M. Potential application of grape derived polyphenols in Huntington's disease. Transl. Neurosci. 2010, 1:95-100.
271. Wang J., Santa-Maria I., Ho L., Ksiezak-Reding H., Ono K., Teplow D.B., Pasinetti G.M. Grape derived polyphenols attenuate tau neuropathology in a mouse model of Alzheimer's disease. J. Alzheimers Dis. 2010, 22:653-661.
272. Wang J., Zhang H.Y., Tang X.C. Huperzine a improves chronic inflammation and cognitive decline in rats with cerebral hypoperfusion. J. Neurosci. Res. 2010, 88:807-815.
273. Wang L.S., Zhou J., Shao X.M., Tang X.C. Huperzine A attenuates cognitive deficits and brain injury after hypoxia-ischemic brain damage in neonatal rats. Zhonghua Er Ke Za Zhi 2003, 41:42-45.
274. Wang Q., Sun A.Y., Simonyi A., Jensen M.D., Shelat P.B., Rottinghaus G.E., MacDonald R.S., Miller D.K., Lubahn D.E., Weisman G.A., Sun G.Y. Neuroprotective mechanisms of curcumin against cerebral ischemia-induced neuronal apoptosis and behavioral deficits. J. Neurosci. Res. 2005, 82:138-148.
275. Wang R., Tang X.C. Neuroprotective effects of huperzine A. A natural cholinesterase inhibitor for the treatment of Alzheimer's disease. Neurosignals 2005, 14:71-82.
276. Wang R., Yan H., Tang X.C. Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine. Acta Pharmacol. Sin. 2006, 27:1-26.
277. Wang R., Zhang H.Y., Tang X.C. Huperzine A attenuates cognitive dysfunction and neuronal degeneration caused by beta-amyloid protein-(1-40) in rat. Eur. J. Pharmacol. 2001, 421:149-156.
278. Wang R., Zhang Y.W., Zhang X., Liu R., Hong S., Xia K., Xia J., Zhang Z., Xu H. Transcriptional regulation of APH-1A and increased gamma-secretase cleavage of APP and Notch by HIF-1 and hypoxia. FASEB J. 2006, 20:1275-1277.
279. Wang T., Tang X.C. Reversal of scopolamine-induced deficits in radial maze performance by (-)-huperzine A: comparison with E2020 and tacrine. Eur. J. Pharmacol. 1998, 349:137-142.
280. Wang Y., Zeng Q.G., Zhang Z.B., Yan R.M., Wang L.Y., Zhu D. Isolation and characterization of endophytic huperzine A-producing fungi from Huperzia serrata. J. Ind. Microbiol. Biotechnol. 2010.
281. Wang Y.E., Yue D.X., Tang X.C. Anti-cholinesterase activity of huperzine A. Zhongguo Yao Li Xue Bao 1986, 7:110-113.
282. Wang Y.J., Thomas P., Zhong J.H., Bi F.F., Kosaraju S., Pollard A., Fenech M., Zhou X.F. Consumption of grape seed extract prevents amyloid-beta deposition and attenuates inflammation in brain of an Alzheimer's disease mouse. Neurotox. Res. 2009, 15:3-14.
283. Warden B.A., Smith L.S., Beecher G.R., Balentine D.A., Clevidence B.A. Catechins are bioavailable in men and women drinking black tea throughout the day. J. Nutr. 2001, 131:1731-1737.
284. Waxman E.A., Lynch D.R. N-methyl-d-aspartate receptor subtypes: multiple roles in excitotoxicity and neurological disease. Neuroscientist 2005, 11:37-49.
285. Wei J., Walton E.A., Milici A., Buccafusco J.J. m1-m5 muscarinic receptor distribution in rat CNS by RT-PCR and HPLC. J. Neurochem. 1994, 63:815-821.
286. Weinreb O., Amit T., Mandel S., Youdim M.B. Neuroprotective molecular mechanisms of (-) epigallocatechin-3-gallate: a reflective outcome of its antioxidant, iron chelating and neuritogenic properties. Genes Nutr. 2009, 4:283-296.
287. Weinreb O., Amit T., Youdim M.B. A novel approach of proteomics and transcriptomics to study the mechanism of action of the antioxidant-iron chelator green tea polyphenol (-)-epigallocatechin-3-gallate. Free Radic. Biol. Med. 2007, 43:546-556.
288. Weinreb O., Mandel S., Amit T., Youdim M.B. Neurological mechanisms of green tea polyphenols in Alzheimer's and Parkinson's diseases. J. Nutr. Biochem. 2004, 15:506-516.
289. Wenger R.H., Gassmann M. Oxygen(es) and the hypoxia-inducible factor-1. Biol. Chem. 1997, 378:609-616.
290. Whitehouse P.J. The cholinergic deficit in Alzheimer's disease. J. Clin. Psychiatry 1998, 59(Suppl. 13):19-22.
291. Williams R.J., Spencer J.P., Rice-Evans C. Flavonoids: antioxidants or signalling molecules?. Free Radic. Biol. Med. 2004, 36:838-849.
292. Wisniewski A.B., Klein S.L., Lakshmanan Y., Gearhart J.P. Exposure to genistein during gestation and lactation demasculinizes the reproductive system in rats. J. Urol. 2003, 169:1582-1586.
293. Xu S.S., Cai Z.Y., Qu Z.W., Yang R.M., Cai Y.L., Wang G.Q., Su X.Q., Zhong X.S., Cheng R.Y., Xu W.A., Li J.X., Feng B. Huperzine-A in capsules and tablets for treating patients with Alzheimer disease. Zhongguo Yao Li Xue Bao 1999, 20:486-490.
294. Xu S.S., Gao Z.X., Weng Z., Du Z.M., Xu W.A., Yang J.S., Zhang M.L., Tong Z.H., Fang Y.S., Chai X.S., et al. Efficacy of tablet huperzine-A on memory, cognition, and behavior in Alzheimer's disease. Zhongguo Yao Li Xue Bao 1995, 16:391-395.
295. Xu Z., Chen S., Li X., Luo G., Li L., Le W. Neuroprotective effects of (-)-epigallocatechin-3-gallate in a transgenic mouse model of amyotrophic lateral sclerosis. Neurochem. Res. 2006, 31:1263-1269.
296. Yamamoto N., Moon J.H., Tsushida T., Nagao A., Terao J. Inhibitory effect of quercetin metabolites and their related derivatives on copper ion-induced lipid peroxidation in human low-density lipoprotein. Arch. Biochem. Biophys. 1999, 372:347-354.
297. Yang J., Li Q., Zhou X.D., Kolosov V.P., Perelman J.M. Naringenin attenuates mucous hypersecretion by modulating reactive oxygen species production and inhibiting NF-kappaB activity via EGFR-PI3K-Akt/ERK MAPKinase signaling in human airway epithelial cells. Mol. Cell. Biochem. 2011, 351:29-40.
298. Yazawa K., Kihara T., Shen H., Shimmyo Y., Niidome T., Sugimoto H. Distinct mechanisms underlie distinct polyphenol-induced neuroprotection. FEBS Lett. 2006, 580:6623-6628.
299. Yuan J., Yankner B.A. Apoptosis in the nervous system. Nature 2000, 407:802-809.
300. Zangara A. The psychopharmacology of huperzine A: an alkaloid with cognitive enhancing and neuroprotective properties of interest in the treatment of Alzheimer's disease. Pharmacol. Biochem. Behav. 2003, 75:675-686.
301. Zeng X.J., Yu S.P., Zhang L., Wei L. Neuroprotective effect of the endogenous neural peptide apelin in cultured mouse cortical neurons. Exp. Cell Res. 2010, 316:1773-1783.
302. Zha J., Harada H., Yang E., Jockel J., Korsmeyer S.J. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 1996, 87:619-628.
303. Zhang F., Shi J.S., Zhou H., Wilson B., Hong J.S., Gao H.M. Resveratrol protects dopamine neurons against lipopolysaccharide-induced neurotoxicity through its anti-inflammatory actions. Mol. Pharmacol. 2010, 78:466-477.
304. Zhang H., Schools G.P., Lei T., Wang W., Kimelberg H.K., Zhou M. Resveratrol attenuates early pyramidal neuron excitability impairment and death in acute rat hippocampal slices caused by oxygen-glucose deprivation. Exp. Neurol. 2008, 212:44-52.
305. Zhang L., Cao H., Wen J., Xu M. Green tea polyphenol (-)-epigallocatechin-3-gallate enhances the inhibitory effect of huperzine A on acetylcholinesterase by increasing the affinity with serum albumin. Nutr. Neurosci. 2009, 12:142-148.
306. Zhang S., Zhang Z., Sandhu G., Ma X., Yang X., Geiger J.D., Kong J. Evidence of oxidative stress-induced BNIP3 expression in amyloid beta neurotoxicity. Brain Res. 2007, 1138:221-230.
307. Zhang X., Zhou K., Wang R., Cui J., Lipton S.A., Liao F.F., Xu H., Zhang Y.W. Hypoxia-inducible factor 1alpha (HIF-1alpha)-mediated hypoxia increases BACE1 expression and beta-amyloid generation. J. Biol. Chem. 2007, 282:10873-10880.
308. Zhang Z., Wang X., Chen Q., Shu L., Wang J., Shan G. [Clinical efficacy and safety of huperzine Alpha in treatment of mild to moderate Alzheimer disease, a placebo-controlled, double-blind, randomized trial]. Zhonghua Yi Xue Za Zhi 2002, 82:941-944.
309. Zhang Z.J., Tong Y., Wang X.Y., Yao S.M., Jin G.X., Wang X.P. Huperzine A as add-on therapy in patients with treatment-resistant schizophrenia: an open-labeled trial. Schizophr. Res. 2007, 92:273-275.
310. Zhao B., Guo Q., Xin W. Free radical scavenging by green tea polyphenols. Methods Enzymol. 2001, 335:217-231.
311. Zhao Q., Tang X.C. Effects of huperzine A on acetylcholinesterase isoforms in vitro: comparison with tacrine, donepezil, rivastigmine and physostigmine. Eur. J. Pharmacol. 2002, 455:101-107.
312. Zheng L.T., Ock J., Kwon B.M., Suk K. Suppressive effects of flavonoid fisetin on lipopolysaccharide-induced microglial activation and neurotoxicity. Int. Immunopharmacol. 2008, 8:484-494.
313. Zhou Y.D., Kim Y.P., Li X.C., Baerson S.R., Agarwal A.K., Hodges T.W., Ferreira D., Nagle D.G. Hypoxia-inducible factor-1 activation by (-)-epicatechin gallate: potential adverse effects of cancer chemoprevention with high-dose green tea extracts. J. Nat. Prod. 2004, 67:2063-2069.
314. Zhou Y.Q., Yang Z.L., Xu L., Li P., Hu Y.Z. Akebia saponin D, a saponin component from Dipsacus asper Wall, protects PC 12 cells against amyloid-beta induced cytotoxicity. Cell Biol. Int. 2009, 33:1102-1110.
315. Zhu D., Wang J., Zeng Q., Zhang Z., Yan R. A novel endophytic Huperzine A-producing fungus, Shiraia sp. Slf14, isolated from Huperzia serrata. J. Appl. Microbiol. 2010, 109:1469-1478.
316. Zijp I.M., Korver O., Tijburg L.B. Effect of tea and other dietary factors on iron absorption. Crit. Rev. Food Sci. Nutr. 2000, 40:371-398.